The incidence of CML is different from one country to another, and the frequency of BCR-ABL breakpoint types is different among ethnic backgrounds (Anand et al., 2012; Hanfstein et al., 2014; Paz-y-Miño et al., 2002). The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.